#ETRA

Last 24h 📈 Bullish 📈1

Last 7 Days 📈 Bullish 📈1 📊1

Last 30 Days 📈 Bullish 📈1 📊1

IPO 📈 Stocks

Electra Therapeutics Targets $342M IPO to Advance Lead Drug Ipsoprubart

September 15, 2026 (just now)

Electra Therapeutics seeks a $342 million Nasdaq listing to fuel Phase III trials for its lead hyperinflammatory syndrome treatment, ipsoprubart, following strong…

ETRA

🌍 AMERICAS Read More →

IPO 📈 Stocks

Electra Therapeutics Targets $977.6 Million Valuation in Nasdaq IPO

September 14, 2026 (1 day ago)

Electra Therapeutics seeks a $977.6 million valuation as it joins a rebounding biotech IPO market, with plans to list on the Nasdaq…

ETRA

🌍 AMERICAS Read More →